Zydus Q1: Novel Molecule Enters Phase I, Global Biosimilar Strategy To Shift?

US Sitagliptin Promise

 
• By Vibha Ravi
  
Business growth
Zydus Has Been Laying Building Blocks For Long Term Growth • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business